Helmholtz Gemeinschaft


Browse by Journal Title

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type
Jump to: 2020 | 2019 | 2010 | 2009 | 2008 | 2002 | 2000 | 1998 | 1996 | 1994


Notch1 in cancer therapy: possible clinical implications and challenges.
Gharaibeh, L. and Elmadany, N. and Alwosaibai, K. and Alshaer, W.
Molecular Pharmacology 98 (5): 559-576. 1 November 2020

Kinetic analysis of the early signaling steps of the human chemokine receptor CXCR4.
Perpina-Viciano, C. and Isbilir, A. and Zarca, A. and Caspar, B. and Kilpatrick, L.E. and Hill, S.J. and Smit, M.J. and Lohse, M.J. and Hoffmann, C.
Molecular Pharmacology 98 (2): 72-87. August 2020


Context-dependent signaling of CXC chemokine receptor 4 and atypical chemokine receptor 3.
Heuninck, J. and Perpina Viciano, C. and Işbilir, A. and Caspar, B. and Capoferri, D. and Briddon, S.J. and Durroux, T. and Hill, S.J. and Lohse, M.J. and Milligan, G. and Pin, J.P. and Hoffmann, C.
Molecular Pharmacology 96 (6): 778-793. December 2019


Simple 2,4-diacylphloroglucinols as classic transient receptor potential-6 activators--identification of a novel pharmacophore.
Leuner, K. and Heiser, J.H. and Derksen, S. and Mladenov, M.I. and Fehske, C.J. and Schubert, R. and Gollasch, M. and Schneider, G. and Harteneck, C. and Chatterjee, S.S. and Mueller, W.E.
Molecular Pharmacology 77 (3): 368-377. March 2010


The sequence after the signal peptide of the g protein-coupled endothelin B receptor is required for efficient translocon gating at the endoplasmic reticulum membrane.
Alken, M. and Schmidt, A. and Rutz, C. and Furkert, J. and Kleinau, G. and Rosenthal, W. and Schuelein, R.
Molecular Pharmacology 75 (4): 801-811. April 2009


Derlin-1 and p97/valosin-containing protein mediate the endoplasmic reticulum-associated degradation of human V2 vasopressin receptors.
Schwieger, I. and Lautz, K. and Krause, E. and Rosenthal, W. and Wiesner, B. and Hermosilla, R.
Molecular Pharmacology 73 (3): 697-708. March 2008


Transcriptional regulation of the rat bradykinin B2 receptor gene: Identification of a silencer element.
Baptista, H.A. and Avellar, M.C.W. and Araujo, R.C. and Pesquero, J.L. and Schanstra, J.P. and Bascands, J.L. and Esteve, J.P. and Paiva, A.C.M. and Bader, M. and Pesquero, J.B.
Molecular Pharmacology 62 (6): 1344-1355. 1 December 2002

Desensitization of homomeric alpha1 glycine receptor increases with receptor density.
Legendre, P. and Muller, E. and Badiu, C.I. and Meier, J. and Vannier, C. and Triller, A.
Molecular Pharmacology 62 (4): 817-827. October 2002


From agonist to antagonist: Fab fragments of an agonist-like monoclonal anti-beta2-adrenoceptor antibody behave as antagonists.
Mijares, A. and Lebesgue, D. and Wallukat, G. and Hoebeke, J.
Molecular Pharmacology 58 (2): 373-379. 1 August 2000

Late endosomal/lysosomal targeting and lack of recycling of the ligand-occupied endothelin B receptor.
Oksche, A. and Boese, G. and Horstmeyer, A. and Furkert, J. and Beyermann, M. and Bienert, M. and Rosenthal, W.
Molecular Pharmacology 57 (6): 1104-1113. June 2000

Molecular and conformational features of a transport-relevant domain in the C-terminal tail of the vasopressin V(2) receptor.
Krause, G. and Hermosilla, R. and Oksche, A. and Rutz, C. and Rosenthal, W. and Schuelein, R.
Molecular Pharmacology 57 (2): 232-242. February 2000


A dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS.M6 cells.
Schuelein, R. and Hermosilla, R. and Oksche, A. and Dehe, M. and Wiesner, B. and Krause, G. and Rosenthal, W.
Molecular Pharmacology 54 (3): 525-535. September 1998


Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
Oksche, A. and Schuelein, R. and Rutz, C. and Liebenhoff, U. and Dickson, J. and Mueller, H. and Birnbaumer, M. and Rosenthal, W.
Molecular Pharmacology 50 (4): 820-828. October 1996


p-Alkoxyphenols, a new class of inhibitors of mammalian R2 ribonucleotide reductase: possible candidates for antimelanotic drugs.
Poetsch, S. and Drechsler, H. and Liermann, B. and Graeslund, A. and Lassmann, G.
Molecular Pharmacology 45 : 792-796. 1 January 1994

This list was generated on Sat Jan 23 02:33:58 2021 CET.
Open Access
MDC Library